# Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

> **NCT01195181** · PHASE4 · COMPLETED · sponsor: **Azienda Ospedaliera di Padova** · enrollment: 506 (actual)

## Conditions studied

- Hepatitis C Virus
- Chronic Liver Disease
- Viral Hepatitis
- Therapeutic Uses
- Antiviral Agents

## Interventions

- **DRUG:** peginterferon plus ribavirin

## Key facts

- **NCT ID:** NCT01195181
- **Lead sponsor:** Azienda Ospedaliera di Padova
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-08
- **Target enrollment:** 506 (ACTUAL)
- **Last updated:** 2010-09-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01195181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01195181, "Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01195181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*